Alyson Wooten, PharmD, focuses her practice on patent litigation with a special emphasis on pharmaceutical patent litigation under the Hatch-Waxman Act.  Registered as a patent attorney and pharmacist, Dr. Wooten also has broad experience in counseling clients on FDA regulatory matters, clinical trial management, early commercialization strategies, patent settlements and licenses, drug products liability, and antitrust issues bearing on pharmaceutical patent settlements. Prior to joining Kilpatrick Townsend, Dr. Wooten worked for a leading pharmaceutical company focusing on Paragraph IV litigation, patent prosecution for new chemical entities, and FDA regulatory issues.